SCCM Resource Library-Pneumonia and Sepsis in Critical Care: Navigating a Complex Patient Diagnostic Workup

Video Transcription

Video Summary

In this video, a panel of experts discuss the use of molecular rapid diagnostic methods for diagnosing pneumonia and sepsis in clinical care. They emphasize the benefits of these tests, including enhanced clinical decision-making, improved outcomes, and cost savings. The panel discusses various molecular diagnostic tests that are available, such as the FilmArray pneumonia panel and the Univero lower respiratory tract panel. They highlight the importance of interpreting the results accurately and using the information to guide antibiotic therapy. The panel also discusses the role of antibiotic stewardship in optimizing the use of antibiotics. They emphasize the importance of a multidisciplinary team approach and the need for collaboration between microbiologists, intensivists, infectious disease specialists, pharmacists, and nurses. The panel concludes by addressing questions from the audience, discussing topics such as the use of biomarkers and patients with multiple drug-resistant infections, and the appropriate timing for starting antibiotics in suspected pneumonia or sepsis cases. Overall, the panel provides insights into the use of molecular rapid diagnostic methods in clinical care and highlights their potential benefits for patients with pneumonia and sepsis.

Asset Subtitle

Quality and Patient Safety, Sepsis, Pharmacology, 2022

Asset Caption

This session will help clinicians improve their awareness and adoption of syndromic panels to improve patient outcomes. Rapid diagnostic methodologies for pathogen identification represent a tremendous advancement over traditional culture-based methods because they enable physicians to quickly identify a causative pathogen and initiate antibiotics. This is especially critical in infections, such as sepsis and pneumonia, in which patient clinical outcomes are highly dependent on the time at which antibiotics are initiated. Learning Objectives: -Discuss the role of multiplex panel testing in the management of critical care patients -Identify the key characteristics of available multiplex panel testing -Identify emerging clinical evidence for the use of biomarkers in critical care patients -Use rapid diagnostic tests in patients suspected of having sepsis This program is supported by an educational grant from bioMerieux

Meta Tag

Content Type Presentation

Knowledge Area Quality and Patient Safety

Knowledge Area Sepsis

Knowledge Area Pharmacology

Knowledge Level Intermediate

Knowledge Level Advanced

Learning Pathway Sepsis Resources

Membership Level Select

Tag Evidence Based Medicine

Tag Infection

Tag Antibiotics

Year 2022

Keywords

molecular rapid diagnostic methods

diagnosing pneumonia

diagnosing sepsis

clinical care

enhanced clinical decision-making

improved outcomes

cost savings

antibiotic stewardship

multidisciplinary team approach

Quality and Patient Safety

Sepsis

Pharmacology

Evidence Based Medicine

Infection

Antibiotics

Presentation

Select

2022

Intermediate

Advanced

Sepsis Resources

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.